DAG1 p.Pro245Leu
c.734C>T · rs780960166 · VCV1445194
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9262 | likely pathogenic |
|---|---|---|
| REVEL | 0.914 | moderately pathogenic-leaning |
| SaProt | LLR -5.67 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2, phastCons 1 |
| Regional constraint | o/e 0.54 | unconstrained · MANE · 229 bp · p 5.6e-06 · regional, not allelic |
| Overall | ||
| CADD | 29.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0165% | 6,062 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,512 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DAG1
- Protein
- p.Pro245Leu
- Coding
- c.734C>T
- MANE Select
- NM_004393
- dbSNP
- rs780960166
- Type
- single nucleotide variant
- Location
- chr3:49531245 (GRCh38)
- Gene constraint
- LOEUF 0.298 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 68.44 · 8 PDB
- Residue 245
- a disulfide bond; the 'required for laminin recognition' region; a β-strand
Disease context
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: autosomal recessive limb-girdle muscular dystrophy type 2P
For Walker-Warburg syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Antenatal, Infancy, Neonatal
- Prevalence
- <1 / 1 000 000 (United Kingdom)
Similar variants
- DAG1 p.Pro245= Conflicting classifications of pathogenicity ★ same residue
- DAG1 p.Ser14Ter Pathogenic ★★ same condition
- DAG1 p.Trp110Ter Pathogenic/Likely pathogenic ★★ same condition
- DAG1 p.Ala135Ser Uncertain significance ★★ ⚠ same condition
- DAG1 p.Ala135Thr Uncertain significance ★★ ⚠ same condition
- DAG1 p.Ala279Ser Uncertain significance ★★ ⚠ same condition
- DAG1 p.Ala285Thr Uncertain significance ★★ ⚠ same condition
- DAG1 p.Ala285Val Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dag1-p-pro245leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown